In 2016 several trainees joined NCRI Groups, enabling them to actively contribute to the development of trials within their areas…
Dr Iain Frame appointed NCRI CEO
Dr Iain Frame has been appointed as the new CEO of the National Cancer Research Institute (NCRI), today (Thursday). Dr Iain…
Developing a consensus for the future of radiotherapy-drug research
Despite increasing numbers of radiotherapy trials and rising recruitment, a continuing challenge has been increasing the number of trials evaluating…
Developing better cancer trials for non-small cell lung cancers
A consortium established by NCRI CTRad and the NCRI Lung Group to address the lack of radiotherapy and drug combination…
CTRad: moving boldly into the next phase 2018-2021
Since its inception in 2009, NCRI’s flagship radiotherapy initiative, the Clinical and Translational Radiotherapy Research Working Group (CTRad), has achieved…
Top 10 research priorities for teenage and young adult cancer identified
Dr Lorna Fern, National Cancer Research Institute Teenage, Young Adult and Germ Cell Clinical Studies Group and Susie Aldiss, University…
NCRI Cancer CTU Group releases new guidelines
Collaboration between clinical trials units (CTUs), working in partnership with clinical investigators (CIs), and pharmaceutical company partners is a key…
NCRI’s Director, Dr Karen Kennedy, to leave the organisation
We are sad to announce that NCRI’s Director, Dr Karen Kennedy, will be leaving the organisation at the end of…
Identifying more harm than good: The PRIMETIME breast cancer study
PRIMETIME is a research study in early breast cancer investigating whether it’s possible to identify a group of women with…
Eliminating age restriction in cancer clinical trials
Ensuring the participants taking part in clinical trials are representative of the disease being studied is essential to ensure that…
Our Living With and Beyond Cancer initiative
Today in the UK, around 2.5 million people have received a cancer diagnosis at some point, and this number is…
The DISCOVERY programme: A programme to change cancer diagnosis
Through the NCRI Early Diagnosis Subgroup* researchers developed the DISCOVERY programme; a series of studies that aimed to better identify…